Cargando…
Recurrent cystoid macular edema following Boston keratoprosthesis type-II implantation: A treatment option
A 68-year-old woman with end-stage Stevens–Johnson syndrome developed cystoid macular edema (CME) 3 months following Boston keratoprosthesis type II (KPro-II) implantation and treated with single-dose injection of triamcinolone acetonide (TA) in the inferior peribulbar region. After 14 days, CME res...
Autores principales: | Basak, Samar K, Basak, Soham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640875/ https://www.ncbi.nlm.nih.gov/pubmed/32709826 http://dx.doi.org/10.4103/ijo.IJO_2322_19 |
Ejemplares similares
-
Challenges of Glaucoma Management in Patients with Type I Boston Keratoprosthesis
por: AlHilali, Sara M, et al.
Publicado: (2022) -
Cystoid macular edema
por: Rotsos, Tryfon G, et al.
Publicado: (2008) -
Outcomes of the Boston Keratoprosthesis in Jordan
por: Shihadeh, Wisam A., et al.
Publicado: (2012) -
Titanium Coating of the Boston Keratoprosthesis
por: Salvador-Culla, Borja, et al.
Publicado: (2016) -
Commentary: An option for treating resistant pseudophakic cystoid macular edema
por: Palanivelu, Mahesh Shanmugam
Publicado: (2021)